Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
97.42 USD | +0.06% | +2.28% | +13.87% |
May. 10 | Barrington Research Raises Price Target on Haemonetics to $107 From $105, Keeps Outperform Rating | MT |
May. 09 | Haemonetics Seeks Acquisitions | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.87% | 4.95B | |
-5.51% | 181B | |
+2.33% | 112B | |
-3.62% | 67.92B | |
+1.52% | 50.1B | |
+8.06% | 44.27B | |
+9.39% | 40.41B | |
+23.35% | 31.95B | |
+0.67% | 25.82B | |
+17.27% | 25.29B |
- Stock Market
- Equities
- HAE Stock
- News Haemonetics Corporation
- Barrington Research's Initial Take on Haemonetics' Acquisition of OpSens